GlassScriptPhysician profile
Carissa L Muller
NPI 1134760374
$3,225.97
in general payments reported to CMS, 2019-2025
18 companies · $3,118 in 2025
The $3,118 reported for 2025 was more than what 98% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $4.43 · 2024: $103 · 2025: $3,118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,821 · Travel and Lodging: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,821.18 |
| Travel and Lodging | $400.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $805.70 | 2025 | Senza, Vyrsa V1 |
| Spinal Simplicity, LLC | $786.46 | 2025 | Ha Minuteman G3-R |
| Biotronik Nro, INC. | $325.76 | 2025 | Prospera |
| Collegium Pharmaceutical, INC. | $315.64 | 2024-2025 | Belbuca |
| Ucb, INC. | $150.28 | 2025 | Briviact, Fintepla |
| Argenx US, INC. | $139.89 | 2025 | Vyvgart, Vyvgart Hytrulo |
| Vertex Pharmaceuticals Incorporated | $122.68 | 2025 | |
| Lundbeck LLC | $97.87 | 2024-2025 | Vyepti |
| Virtus Pharmaceuticals LLC | $76.74 | 2025 | Levorphanol Tartrate |
| Valinor Pharma, LLC | $68.75 | 2025 | Movantik |
| Axsome Therapeutics, INC. | $66.11 | 2025 | Symbravo |
| Eisai INC. | $62.76 | 2024 | |
| Lilly USA, LLC | $61.39 | 2025 | Kisunla, Amyvid |
| Jazz Pharmaceuticals INC. | $43.24 | 2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $40.12 | 2025 | Relistor |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $33.18 | 2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $24.97 | 2025 | Hyqvia |
| Genentech USA, INC. | $4.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carissa Muller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.